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ABSTRACT
Objectives: Intravascular accumulations of atypical large 
lymphoid cells are a rare finding in skin biopsy specimens 
and raise the suspicion for intravascular lymphoma. The 
intravascular accumulation of atypical large CD30+ T cells, 
however, as a reactive process is very uncommon in the skin, 
with only four cases documented so far in the literature. 
This condition, referred to as benign intravascular atypical 
CD30+ T-cell proliferation, has been associated with 
chronic inflammation after trauma.
Methods: We report on a case of atypical intravascular 
CD30+ T-cell proliferation in a patient with ulcerated lichen 
sclerosus on the foreskin, discuss the differential diagnoses, 
propose diagnostic criteria, and review the literature on 
this uncommon reactive intralymphatic CD30+ T-cell 
lymphoproliferation.
Results: The atypical intravascular CD30+ T-cell 
proliferation is characterized by the accumulation of large 
CD30+ polyclonal T cells within lymphatics in close vicinity 
to ulceration or an inflammatory skin disease. There is no 
association with Epstein-Barr virus infection.
Conclusions: This benign cutaneous lymphoproliferation 
needs to be distinguished from intravascular T-cell 
lymphoma, particularly from the intravascular variant of 
anaplastic large cell lymphoma. Obstruction of lymphatics 
due to lichen sclerosus with disrupted immune cell trafficking 
may result in the accumulation of activated CD30+ 
lymphocytes.
The presence of intravascular large atypical lymphocytes 
raises the suspicion for intravascular lymphoma (IVL) or 
leukemia. IVL is an aggressive disease, which most commonly 
represents a diffuse large B-cell lymphoma with predominantly 
intravascular growth, but a very rare T-cell variant has been 
described, including cases with expression of CD30 by 
tumor cells.1-5 On the other hand, primary cutaneous CD30+ 
lymphoproliferative diseases (CD30+ LPDs) encompass a 
spectrum of diseases such as lymphomatoid papulosis (LyP), 
primary cutaneous anaplastic large-cell lymphoma (ALCL), 
and so-called borderline lesions, with all exhibiting an 
excellent prognosis.6-8 The tumor cells in CD30+ LPDs 
mostly are large pleomorphic or anaplastic T cells. The 
expression of CD30, however, is not restricted to lymphomas. 
An increasing number of reactive conditions are known to 
harbor atypical medium- to large-sized CD30+ T cells, such as 
infestations, viral infections, and drug eruptions.6,9 Recently, 
benign proliferation of intravascular atypical CD30+ T cells 
as a reactive process due to trauma was described, but so far, 
only a few cases have been reported.10,11 We present a case 
of benign atypical intravascular CD30+ T-cell proliferation 
occurring in a patient with focally ulcerated lichen sclerosus 
(LS) on the foreskin and review the literature on this reactive 
lymphoproliferation, which may mimic IVL.
Case Report
A 46-year-old man had LS with white, sclerotic, focally 
eroded areas (up to 1 cm in diameter) on the prepuce, which 
slowly had increased to 7 cm in diameter over several months, 
before seeking treatment at the department of urology to 
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undergo circumcision. His medical history showed no chronic 
disease or long-term medications.
The histologic examination of the prepuce showed 
the characteristic features of LS with vacuolization of the 
junctional zone, subepidermal hyalinized collagen tissue, 
and a band-like predominantly lymphocytic infiltrate ❚Image 
1A❚ and ❚Image 1B❚. The lymphocytes were small sized, 
with chromatin-dense nuclei lacking atypia, and were 
admixed with a few slightly enlarged lymphocytes. At 
scanning magnification, thin-walled ectatic vessels filled 
with medium- to large-sized blasts were discernible in 
the superficial dermis ❚Image 2A❚ and ❚Image 2B❚. These 
large lymphoid cells displayed pleomorphic and slightly 
polymorphic nuclei containing small and occasional large 
nucleoli and showed a moderate eosinophilic cytoplasmic rim, 
staining basophilic with the Giemsa stain. Occasionally, similar 
lymphoid cells expanded in the perivascular tissue admixed to 
some histiocytes, plasma cells, and rare eosinophils. Subtle 
erythrocyte extravasation but no vasculitic changes were 
present. Immunohistochemical analysis demonstrated that the 
❚Image 1❚ A, Lichen sclerosus et atrophicans on the prepuce with vacuolization of the junctional zone, subepidermal hyalinized 
collagen tissue, and a predominantly lymphocytic infiltrate (H&E, ×100). B, Focal epidermal ulceration and enlarged thin-walled 
vessels filled with lymphoid cells in the underlying dermal tissue (H&E, ×25).
A B
A B
❚Image 2❚ The intravascular lymphoid cells encompass medium- to large-sized cells demonstrating pleomorphic nuclei 
with finely dispersed chromatin, prominent to small nucleoli, and a moderate amount of cytoplasm, some with mitosis and 
intermingled small lymphocytes with chromatin-dense nuclei (A, H&E, ×400; B, Giemsa, ×400).
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intravascular atypical medium- to large-sized lymphocytes 
expressed CD2, CD3, CD4, CD5, and CD45, with partial 
expression of CD7 and with concomitant expression of CD30 
in 90% of the cells ❚Image 3A❚. Anaplastic lymphoma kinase 1 
(ALK-1), epithelial membrane antigen (EMA), CD1a, CD56, 
and CD43 were not expressed. B-cell markers, including 
CD20 and CD79a, were consistently negative. Epstein-Barr 
virus–encoded small RNA (EBER) in situ hybridization 
(ISH) was negative. The endothelial cells lining the ectatic 
vessels were positive for CD31 and podoplanin and negative 
for CD34 ❚Image 3B❚, indicating lymphatic vessels. T-cell 
receptor (TCR) g genotyping using specific polymerase chain 
reaction (PCR) (Vg1-8, Vg9, Vg10-12, Jg1/2, JgP1/2, and 
JgP primers) and fragment analysis as well as PCR-based 
clonality assays using a BIOMED2 protocol revealed a 
polyclonal T-cell population.12
Since clinical examination was unremarkable, without 
any signs of extracutaneous lymphoma, and peripheral blood 
leukocyte counts did not reveal leukemia, a wait-and-see 
strategy was suggested. During the follow-up period of 21 
months, the health status of the patient was unremarkable, 
with no signs of lymphoma or leukemia or episodes of fever 
or weight loss. Blood tests at diagnosis and during follow-up 
were normal.
Discussion
Intravascular accumulations of atypical large lymphoid 
cells are a rare finding in skin biopsy specimens and raise 
the suspicion for IVL. Most cases of IVL are of B-cell origin 
and represent a form of diffuse large B-cell lymphoma, 
with a predominantly intravascular proliferation of tumor 
cells.13 A subset of IVL is of T-cell origin. In a series of 
50 cases of intravascular large natural killer (NK)–cell and 
T-cell lymphomas, the tumor cells were positive for T-cell 
markers CD2 and CD3 and, in most cases, for the NK-cell 
marker CD56.1 Furthermore, the cells expressed cytotoxic 
proteins, and in most cases, EBER could be detected by 
ISH. The phenotype resembled that of extranodal NK-/T-cell 
lymphoma, nasal type. Clinically, IVL displays erythema 
nodosum-like lesions, painful telangiectasias, or livedo 
racemosa skin lesions.14 The prognosis of IVL, independent 
of T- or B-cell origin, is unfavorable, with a 3-year survival 
rate of 33% for the systemic form of IVL and a relatively 
better prognosis in its cutaneous form. Expression of CD30 
is usually not present in IVL but is a consistent and defining 
feature of intravascular ALCL (IV-ALCL). So far, fewer 
than 10 cases of IV-ALCL have been documented in the 
literature, including four cases restricted to the skin2-5 and two 
patients with secondary cutaneous involvement by systemic 
ALCL.15,16 In contrast to T-cell IVL, IV-ALCL expresses 
CD4 and CD30 but is negative for cytotoxic markers and 
EBER. Expression of ALK-1 and EMA, which is a common 
finding in systemic ALCL, is rarely present in IV-ALCL. 
Monoclonal rearrangement of TCR g genes was documented 
in some cases of IV-ALCL. Clinically, IV-ALCL manifests 
with patches and plaques or nodular lesions.3,4 The data on the 
prognosis of IV-ALCL are heterogeneous and do not allow 
drawing stringent conclusions. In addition to IV-ALCL, the 
angioinvasive form of LyP (referred to as LyP type E) has 
to be included in the differential diagnosis.17 In this variant 
A B
❚Image 3❚ A, Immunophenotype of intravascular lymphocytes that express CD3, CD4, and CD30 with 90% of the cells being 
positive for the latter antigen (×400). B, Expression of CD3, CD4, and a partial loss of CD7 expression (approximately 30% of the 
cells) as well as negativity for CD20. Expression of podoplanin by the endothelial cells lining the ectatic vessels (×400).
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of LyP, dermal and subcutaneous vessels are infiltrated 
and destroyed by medium- to large-sized atypical CD30+ 
cells, resulting in dermal necrosis and hemorrhage. In some 
cases, the atypical cells may occlude the vessel lumina. The 
infiltration and destruction of vessel walls and extensive 
hemorrhage allow distinction of LyP type E from benign 
atypical intravascular CD30+ T-cell proliferation.
The atypical cytomorphology of the intravascular large 
CD30+ cells in our patient is at first glance suggestive of 
IVL. However, the context of an inflammatory skin disease 
with ulceration and the absence of other signs or symptoms 
of lymphoma, particularly the indolent clinical course, argue 
against malignancy and suggest a reactive intravascular T-cell 
proliferation in the context of a focally ulcerated LS. So far, 
only three cases of intravascular atypical large CD30+ cell 
proliferation have been documented ❚Table 1❚.10,11 The first 
case was a 17-year-old male patient described by Baum and 
coworkers,10 who observed an intravascular proliferation 
of CD30+ T cells in the context of a dermal inflammatory 
infiltrate after a trauma on the arm. Recently, Riveiro-
Falkenbach et al11 reported two patients with intravascular 
atypical CD30+ T cells. The first patient, a 45-year-old 
man, had a 2.5-cm ulcerated cutaneous nodule on the 
trunk. The second was a 17-year-old female patient with a 
4-month history of an ulcerated and exophytic cutaneous 
laterocervical lesion having developed after a trauma. These 
reports demonstrate that trauma with destruction of the 
epidermal layer represents a major trigger factor for the 
accumulation of large CD30+ T cells in superficial vascular 
channels. To our knowledge, we describe the first case of 
benign atypical intravascular CD30+ T-cell proliferation 
occurring in an (ulcerated) area of LS representing a chronic 
autoimmunologic skin disease. The repertoire of homing 
factors for these activated intravascular T cells in benign 
intravascular T-cell proliferations is widely unknown. In 
one report, CCR7 was expressed by reactive intravascular T 
cells, but less than 5% of the intravascular T cells expressed 
CD30 antigen in that case.18 CD30 is a transmembrane 
glycoprotein representing a member of the tumor necrosis 
factor receptor superfamily and plays a role in regulating the 
function or proliferation of normal lymphoid cells.19 CD30 is 
physiologically expressed by activated lymphoid cells and is 
observed in many inflammatory cutaneous diseases, usually 
affecting a small number of stimulated and histologically 
enlarged T cells. Reactive conditions harboring a significant 
number of activated CD30+ T cells are referred to as CD30+ 
pseudolymphomas.6 Atypical enlarged CD30+ T cells were 
observed in inflammatory and infectious disorders such as 
molluscum contagiosum, viral warts, pityriasis lichenoides, 
or drug eruptions.6,9,20 We did not find any reports on the 
presence of CD30+ T cells in LS. In reactive conditions, 
CD30+ T cells are usually found as single units or small 
❚Table 1❚
Cutaneous Benign Atypical Intravascular CD30+ T-Cell Proliferation:  
Clinicopathologic Features of the Cases Reported in the Literature and the Presented Case
Case Sex/Age, y Location Clinical Presentation Staging Phenotype TCR Therapy Follow-up
Baum et al, 200910 M/17 Right 
forearm
Seven- to 8-week 
history of a 1.7 × 
1.3-cm erythematous 
patch with central 
erosion and peripheral 
collarette of scale after 
trauma
Negative 
(blood)
CD4+ 
(60%), 
CD30+
Oligoclonal SE CR, NR 8 
mo
Ardighieri et al, 201018 F/69 Arm Solitary lesion 
(diameter: 10 mm) 
on the arm, clinically 
diagnosed as pyogenic 
granuloma and 
removed by shave 
biopsy
Negative CD4+, 
CD30+
Polyclonal Shave 
biopsy
CR, NR 9 
mo
Riveiro-Falkenbach et al, 
201311
M/45 Trunk Few-week history of 
a 2.5-cm ulcerated 
cutaneous nodule on 
the trunk
Negative CD4+, 
CD30+
Polyclonal RT CR, NR 23 
mo
Riveiro-Falkenbach et al, 
201311
F/17 Neck Four-month history 
of ulcerated and 
exophytic cutaneous 
laterocervical lesion 
developed after a 
trauma
NA CD3+, 
CD30+
NA Shave 
biopsy
CR, NR 24 
mo
Present case M/46 Prepuce Ulcerated 
hypopigmented lesion 
on the prepuce of less 
than 1 cm in diameter
Negative CD4+, 
CD30+
Polyclonal SE CR, NR 21 
mo
CR, complete remission; NA, no data available; NR, no recurrence; RT, radiotherapy; SE, surgical excision; TCR, T-cell receptor g gene rearrangement analysis.
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clusters in the background of small lymphocytes, neutrophils, 
eosinophils, and plasma cells. Usually, the stimulated blasts 
show a normal T-cell phenotype. The partial or complete 
loss of CD7, as observed in our case, is less specific for an 
aberrant T-cell phenotype compared with the loss of other 
T-cell–associated antigens indicative of lymphoma, since this 
phenomenon may be observed in inflammatory dermatoses. 
Molecular studies revealed polyclonal T cells in virtually 
all cases and therefore may represent a useful adjunctive 
diagnostic marker. In our case, no clonal T cells were detected 
by PCR and fragment analysis. Nevertheless, one has to keep 
in mind that monoclonal T cells can be found in LS specimens, 
and therefore detection of clonality in such a scenario may be 
prone to misinterpretation as a hint for malignancy.21 We 
propose diagnostic criteria for atypical CD30+ intravascular 
T-cell proliferation, as listed in ❚Table 2❚.
In our case, the enlarged atypical CD30+ cells were 
located within lymphatic vessels, as underlined by expression 
of podoplanin by the endothelial cells lining the ectatic 
dermal vessels. The photomicrographs and descriptions of 
histologic findings in the other cases reported in the literature 
also suggest that the CD30+ cells are mostly located within 
lymphatic vessels. Therefore, the term benign atypical 
“intralymphatic” CD30+ T-cell proliferation may be more 
precise than employing the more general term, intravascular 
T-cell proliferation, as proposed by Ardighieri et al18 for 
a similar but widely CD30-negative intravascular T-cell 
proliferation in a cutaneous hemangioma. Pathogenetically, 
obstruction of lymphatics due to chronic inflammation 
with disrupted immune cell trafficking may result in the 
accumulation of activated CD30-positive lymphocytes in LS 
or chronic inflammation after trauma.22
In conclusion, we present a case of benign atypical 
intravascular CD30+ T-cell proliferation occurring in the 
area of LS with ulceration. The intralymphatic large CD30+ 
❚Table 2❚
Diagnostic Criteria for Atypical Intravascular  
CD30+ T-Cell Proliferation
1. Association with trauma, ulceration, and/or inflammatory 
processes
2. Intralymphatic accumulation of medium- to large-sized activated 
lymphocytes
3. Expression of T-cell markers and CD30 and lack of B-cell 
marker expression by the medium- and large-sized intravascular 
lymphocytes
4. No loss of T-cell markers (eg, CD3; except for CD7) and 
absence of Epstein-Barr virus (EBV) RNA or EBV-associated 
proteins in the atypically appearing CD30+ lymphocytes
5. Absence of monoclonal rearrangement of T-cell receptor b or g 
genes
6. No indication for cutaneous or systemic lymphoma by staging 
examinations
7. Indolent course with complete resolution after regression of 
ulceration or inflammatory process; no development of lymphoma 
during follow-up
T cells of the helper phenotype represent activated cells most 
probably trafficking between the area of chronic inflammation 
and the regional lymph nodes in a clinically inapparent mode. 
Pathologists and dermatopathologists should be aware of this 
rare and unusual finding to avoid misinterpretation as IVL.
Address reprint requests to Dr Dommann-Scherrer: Institute of 
Pathology, Kantonsspital Winterthur, Brauerstrasse 15, CH-8401 
Winterthur, Switzerland; corina.dommann@ksw.ch.
References
 1. Cerroni L, Massone C, Kutzner H, et al. Intravascular large 
T-cell or NK-cell lymphoma: a rare variant of intravascular 
large cell lymphoma with frequent cytotoxic phenotype and 
association with Epstein-Barr virus infection. Am J Surg 
Pathol. 2008;32:891-898.
 2. Zizi-Sermpetzoglou A, Petrakopoulou N, Tepelenis N, et al. 
Intravascular T-cell lymphoma of the vulva, CD30 positive: a 
case report. Eur J Gynaecol Oncol. 2009;30:586-588.
 3. Wang L, Li C, Gao T. Cutaneous intravascular anaplastic 
large cell lymphoma. J Cutan Pathol. 2011;38:221-226.
 4. Iacobelli J, Spagnolo DV, Tesfai Y, et al. Cutaneous intravascular 
anaplastic large T-cell lymphoma: a case report and review of the 
literature. Am J Dermatopathol. 2012;34:e133-e138.
 5. Metcalf RA, Bashey S, Wysong A, et al. Intravascular 
ALK-negative anaplastic large cell lymphoma with localized 
cutaneous involvement and an indolent clinical course: 
toward recognition of a distinct clinicopathologic entity. Am 
J Surg Pathol. 2013;37:617-623.
 6. Kempf W. CD30+ lymphoproliferative disorders: 
histopathology, differential diagnosis, new variants, and 
simulators. J Cutan Pathol. 2006;33(suppl 1):58-70.
 7. de Leval L, Gaulard P. CD30+ lymphoproliferative disorders. 
Haematologica. 2010;95:1627-1630.
 8. Kempf W, Pfaltz K, Vermeer MH, et al. EORTC, ISCL, 
and USCLC consensus recommendations for the treatment 
of primary cutaneous CD30-positive lymphoproliferative 
disorders: lymphomatoid papulosis and primary cutaneous 
anaplastic large-cell lymphoma. Blood. 2011;118:4024-4035.
 9. Werner B, Massone C, Kerl H, et al. Large CD30-positive 
cells in benign, atypical lymphoid infiltrates of the skin. J 
Cutan Pathol. 2008;35:1100-1107.
 10. Baum CL, Stone MS, Liu V. Atypical intravascular CD30+ 
T-cell proliferation following trauma in a healthy 17-year-old 
male: first reported case of a potential diagnostic pitfall and 
literature review. J Cutan Pathol. 2009;36:350-354.
 11. Riveiro-Falkenbach E, Fernandez-Figueras MT, Rodriguez-
Peralto JL. Benign atypical intravascular CD30(+) T-cell 
proliferation: a reactive condition mimicking intravascular 
lymphoma. Am J Dermatopathol. 2013;35:143-150.
 12. van Dongen JJ, Langerak AW, Bruggemann M, et al. Design 
and standardization of PCR primers and protocols for 
detection of clonal immunoglobulin and T-cell receptor gene 
recombinations in suspect lymphoproliferations: report of the 
BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 
2003;17:2257-2317.
 13. Ferreri AJ, Campo E, Seymour JF, et al. Intravascular 
lymphoma: clinical presentation, natural history, 
management and prognostic factors in a series of 38 cases, 
with special emphasis on the ‘cutaneous variant’. Br J 
Haematol. 2004;127:173-183.
AJCP / Case Report
 Am J Clin Pathol  2014;142:694-699 699
 DOI: 10.1309/AJCPXOE61CJDOAJI 
© American Society for Clinical Pathology
 14. Roglin J, Boer A. Skin manifestations of intravascular 
lymphoma mimic inflammatory diseases of the skin. Br J 
Dermatol. 2007;157:16-25.
 15. Krishnan C, Moline S, Anders K, et al. Intravascular 
ALK-positive anaplastic large-cell lymphoma mimicking 
inflammatory breast carcinoma. J Clin Oncol. 2009;27:2563-2565.
 16. Rieger KE, Polidore T, Warnke R, et al. ALK-negative 
systemic intravascular anaplastic large cell lymphoma 
presenting in the skin. J Cutan Pathol. 2011;38:216-220.
 17. Kempf W, Kazakov DV, Scharer L, et al. Angioinvasive 
lymphomatoid papulosis: a new variant simulating aggressive 
lymphomas. Am J Surg Pathol. 2013;37:1-13.
 18. Ardighieri L, Lonardi S, Vermi W, et al. Intralymphatic 
atypical T-cell proliferation in a cutaneous hemangioma. J 
Cutan Pathol. 2010;37:497-503.
 19. de Bruin PC, Gruss HJ, van der Valk P, et al. CD30 
expression in normal and neoplastic lymphoid tissue: 
biological aspects and clinical implications. Leukemia. 
1995;9:1620-1627.
 20. Kempf W, Kazakov DV, Palmedo G, et al. Pityriasis 
lichenoides et varioliformis acuta with numerous CD30+ 
cells: a variant mimicking lymphomatoid papulosis 
and other cutaneous lymphomas: a clinicopathologic, 
immunohistochemical, and molecular biological study of 13 
cases. Am J Surg Pathol. 2012;36:1021-1029.
 21. Lukowsky A, Muche JM, Sterry W, et al. Detection of 
expanded T cell clones in skin biopsy samples of patients 
with lichen sclerosus et atrophicus by T cell receptor-
gamma polymerase chain reaction assays. J Invest Dermatol. 
2000;115:254-259.
 22. Carlson JA, Carlson GD, Murphy M, et al. Lichen sclerosus 
exhibiting histologic signs of lymphedema: an essential factor 
in the pathogenesis of verruciform xanthoma. Arch Dermatol. 
2012;148:260-262.
